These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 32426802)

  • 1. Targeting RLIP with CRISPR/Cas9 controls tumor growth.
    Singhal J; Chikara S; Horne D; Awasthi S; Salgia R; Singhal SS
    Carcinogenesis; 2021 Feb; 42(1):48-57. PubMed ID: 32426802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of mammary carcinogenesis in MMTV-neu mice by targeting RLIP.
    Singhal J; Kulkarni P; Horne D; Awasthi S; Salgia R; Singhal SS
    Mol Carcinog; 2021 Mar; 60(3):213-223. PubMed ID: 33544936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RLIP: An existential requirement for breast carcinogenesis.
    Singhal SS; Salgia R; Singhal S; Horne D; Awasthi S
    Biochim Biophys Acta Rev Cancer; 2019 Apr; 1871(2):281-288. PubMed ID: 30771458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New vectors for simple and streamlined CRISPR-Cas9 genome editing in Saccharomyces cerevisiae.
    Laughery MF; Hunter T; Brown A; Hoopes J; Ostbye T; Shumaker T; Wyrick JJ
    Yeast; 2015 Dec; 32(12):711-20. PubMed ID: 26305040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postnatal Cardiac Gene Editing Using CRISPR/Cas9 With AAV9-Mediated Delivery of Short Guide RNAs Results in Mosaic Gene Disruption.
    Johansen AK; Molenaar B; Versteeg D; Leitoguinho AR; Demkes C; Spanjaard B; de Ruiter H; Akbari Moqadam F; Kooijman L; Zentilin L; Giacca M; van Rooij E
    Circ Res; 2017 Oct; 121(10):1168-1181. PubMed ID: 28851809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting mutant
    Kim W; Lee S; Kim HS; Song M; Cha YH; Kim YH; Shin J; Lee ES; Joo Y; Song JJ; Choi EJ; Choi JW; Lee J; Kang M; Yook JI; Lee MG; Kim YS; Paik S; Kim HH
    Genome Res; 2018 Mar; 28(3):374-382. PubMed ID: 29326299
    [No Abstract]   [Full Text] [Related]  

  • 8. Doxycycline-Dependent Self-Inactivation of CRISPR-Cas9 to Temporally Regulate On- and Off-Target Editing.
    Kelkar A; Zhu Y; Groth T; Stolfa G; Stablewski AB; Singhi N; Nemeth M; Neelamegham S
    Mol Ther; 2020 Jan; 28(1):29-41. PubMed ID: 31601489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR/Cas9 Technology in Translational Biomedicine.
    Leonova EI; Gainetdinov RR
    Cell Physiol Biochem; 2020 Apr; 54(3):354-370. PubMed ID: 32298553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual-sgRNA CRISPR/Cas9 knockout of PD-L1 in human U87 glioblastoma tumor cells inhibits proliferation, invasion, and tumor-associated macrophage polarization.
    Fierro J; DiPasquale J; Perez J; Chin B; Chokpapone Y; Tran AM; Holden A; Factoriza C; Sivagnanakumar N; Aguilar R; Mazal S; Lopez M; Dou H
    Sci Rep; 2022 Feb; 12(1):2417. PubMed ID: 35165339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of a generic CRISPR-Cas9 approach using the same sgRNA to perform gene editing at distinct loci.
    Najah S; Saulnier C; Pernodet JL; Bury-Moné S
    BMC Biotechnol; 2019 Mar; 19(1):18. PubMed ID: 30894153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Split-and-Click" sgRNA.
    Taemaitree L; Shivalingam A; El-Sagheer AH; Brown T
    Methods Mol Biol; 2021; 2162():61-78. PubMed ID: 32926378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-Wide CRISPR Screen Identifies Regulators of Mitogen-Activated Protein Kinase as Suppressors of Liver Tumors in Mice.
    Song CQ; Li Y; Mou H; Moore J; Park A; Pomyen Y; Hough S; Kennedy Z; Fischer A; Yin H; Anderson DG; Conte D; Zender L; Wang XW; Thorgeirsson S; Weng Z; Xue W
    Gastroenterology; 2017 Apr; 152(5):1161-1173.e1. PubMed ID: 27956228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast Cancer Transcriptional Regulatory Network Reprogramming by using the CRISPR/Cas9 System: An Oncogenetics Perspective.
    Singh DD; Verma R; Tripathi SK; Sahu R; Trivedi P; Yadav DK
    Curr Top Med Chem; 2021; 21(31):2800-2813. PubMed ID: 34477520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene Editing in B-Lymphoma Cell Lines Using CRISPR/Cas9 Technology.
    Bai B; Myklebust JH; Wälchli S
    Methods Mol Biol; 2020; 2115():445-454. PubMed ID: 32006416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR/Cas9-mediated 2-sgRNA cleavage facilitates pseudorabies virus editing.
    Tang YD; Guo JC; Wang TY; Zhao K; Liu JT; Gao JC; Tian ZJ; An TQ; Cai XH
    FASEB J; 2018 Aug; 32(8):4293-4301. PubMed ID: 29509513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient Editing of the Nuclear
    Guzmán-Zapata D; Sandoval-Vargas JM; Macedo-Osorio KS; Salgado-Manjarrez E; Castrejón-Flores JL; Oliver-Salvador MDC; Durán-Figueroa NV; Nogué F; Badillo-Corona JA
    Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30871076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid and marker-free gene replacement in citric acid-producing Aspergillus tubingensis (A. niger) WU-2223L by the CRISPR/Cas9 system-based genome editing technique using DNA fragments encoding sgRNAs.
    Yoshioka I; Kirimura K
    J Biosci Bioeng; 2021 Jun; 131(6):579-588. PubMed ID: 33612423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome Editing in Potato with CRISPR/Cas9.
    Nadakuduti SS; Starker CG; Voytas DF; Buell CR; Douches DS
    Methods Mol Biol; 2019; 1917():183-201. PubMed ID: 30610637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR-Cas9-Guided Genome Engineering in C. elegans.
    Kim HM; Colaiácovo MP
    Curr Protoc Mol Biol; 2016 Jul; 115():31.7.1-31.7.18. PubMed ID: 27366893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.